Metraipolis › archive › dc_de4d397b5679

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40956616
DOI
10.1172/jci193956
License (as archived)
solo-consultazione
Archived
2026-11-09T22:22:29.476Z
SHA-256 of the archived text
2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db
Stable URL of this page
https://metraipolis.com/documento/dc_de4d397b5679

How to cite

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616 — Europe PMC (en), https://europepmc.org/article/MED/40956616 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de4d397b5679 (Metraipolis archive dc_de4d397b5679, sha256 2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db)
BibTeX
@misc{dcde4d397b5679,
  title = {Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy — Europe PMC PMID:40956616},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40956616},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de4d397b5679; sha256 2c49129cca491b7fd1b5942de70d883f54066213ef8c0a71a5bfc0342787d8db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40956616. Agents can read the archived copy with the MCP tool read_document.